Burning Rock Biotech Limited (BNR) Misses Q4 EPS by 2c

Burning Rock Biotech Limited (NASDAQ: BNR) reported Q4 EPS of ($0.02). Revenue for the quarter came in at $18.06 million.

For earnings history and earnings-related data on Burning Rock Biotech Limited (BNR) click here.

You May Also Be Interested In

• Barrick Mining said to delay IPO of American gold business to 2027
• Active options: GOOGL SPCX PCG AVGO MSFT AMD SOFI MSTR NFLX IREN ORCL
• Thoma Bravo's Proofpoint Is Said In Talks To Acquire Varonis - Bloomberg